SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-001651
Filing Date
2006-03-16
Accepted
2006-03-16 14:37:20
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - ALNYLAM PHARMACEUTICALS, INC. b58496ape10vk.htm 10-K 1392542
2 EX-10.39 AMENDMENT NO. 1 TO ADDENDUM b58496apexv10w39.txt EX-10.39 4054
3 EX-21.1 - SUBSIDIARIES OF THE REGISTRANT b58496apexv21w1.htm EX-21.1 1840
4 EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP b58496apexv23w1.txt EX-23.1 952
5 EX-31.1 - SEC 302 CERTIFICATION OF CEO b58496apexv31w1.htm EX-31.1 8373
6 EX-31.2 - SEC 302 CERTIFICATION OF CFO b58496apexv31w2.htm EX-31.2 8664
7 EX-32.1 - SEC 906 CERTIFICATION OF CEO b58496apexv32w1.htm EX-32.1 3164
8 EX-32.2 - SEC 906 CERTIFICATION OF CFO b58496apexv32w2.htm EX-32.2 3150
9 GRAPHIC b58496apb5849601.gif GRAPHIC 10397
  Complete submission text file 0000950135-06-001651.txt   1438681
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50743 | Film No.: 06691350
SIC: 2834 Pharmaceutical Preparations